Healthcare provider profile · identity verified

Timothy Brian Cummings, MD

Internal Medicine · ROSWELL, GA · NPI 1720095177

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Prednisone	Prednisone	224	106
Levothyroxine Sodium	Levothyroxine Sodium	138	36
Atorvastatin Calcium	Atorvastatin Calcium	127	37
Amlodipine Besylate	Amlodipine Besylate	118	34
Losartan Potassium	Losartan Potassium	118	38
Rosuvastatin Calcium	Rosuvastatin Calcium	112	31
Zolpidem Tartrate	Zolpidem Tartrate	92	29
Amoxicillin	Amoxicillin	84	29
Azithromycin	Azithromycin	80	60
Lisinopril	Lisinopril	67	19
Alprazolam	Alprazolam	64	15
Eliquis	Apixaban	49	15
Escitalopram Oxalate	Escitalopram Oxalate	49	17
Metoprolol Succinate	Metoprolol Succinate	49	14
Gabapentin	Gabapentin	48	19
Synthroid	Levothyroxine Sodium	47	13
Tamsulosin Hcl	Tamsulosin Hcl	45	15
Montelukast Sodium	Montelukast Sodium	44	11
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	14
Pantoprazole Sodium	Pantoprazole Sodium	42	13
Trazodone Hcl	Trazodone Hcl	41	11
Omeprazole	Omeprazole	40	14
Tramadol Hcl	Tramadol Hcl	39	suppressed
Simvastatin	Simvastatin	33	suppressed
Estradiol (Twice Weekly)	Estradiol	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	18
Clonazepam	Clonazepam	28	suppressed
Estradiol	Estradiol	28	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	12
Atenolol	Atenolol	25	suppressed
Furosemide	Furosemide	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Metformin Hcl	Metformin Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Famotidine	Famotidine	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	12
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Fluconazole	Fluconazole	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	12
Testosterone	Testosterone	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Mupirocin	Mupirocin	16	11
Valsartan	Valsartan	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Diazepam	Diazepam	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	11
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ozempic	Semaglutide	12	suppressed
Almotriptan Malate	Almotriptan Malate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Linzess	Linaclotide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error